Avexxin’s advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Our discovery and clinical development expertise is focused on providing disease-modifying drugs addressing inflammatory disorders that are not adequately treated with existing therapies.
